These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7984289

  • 21. 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital.
    Barann M, Göthert M, Bönisch H, Dybek A, Urban BW.
    Neuropharmacology; 1997; 36(4-5):655-64. PubMed ID: 9225291
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.
    Hand TH, Marek GJ, Seiden LS.
    Psychopharmacology (Berl); 1991; 105(4):453-8. PubMed ID: 1771213
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells.
    Barann M, Bönisch H, Urban BW, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):145-52. PubMed ID: 9749998
    [Abstract] [Full Text] [Related]

  • 24. Increasing effect of ethanol on 5-HT3 receptor-mediated 14C-guanidinium influx in N1E-115 neuroblastoma cells.
    Barann M, Ruppert K, Göthert M, Bönisch H.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):149-56. PubMed ID: 7477437
    [Abstract] [Full Text] [Related]

  • 25. Target size of 5-HT3 receptors in N1E-115 neuroblastoma cells and rat brain.
    Lummis SC, Nielsen M, Kilpatrick GJ, Martin IL.
    Eur J Pharmacol; 1990 Sep 18; 189(2-3):229-32. PubMed ID: 2253705
    [Abstract] [Full Text] [Related]

  • 26. 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells.
    Kooyman AR, van Hooft JA, Vijverberg HP.
    Br J Pharmacol; 1993 Feb 18; 108(2):287-9. PubMed ID: 7680589
    [Abstract] [Full Text] [Related]

  • 27. Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930.
    Neijt HC, Karpf A, Schoeffter P, Engel G, Hoyer D.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May 18; 337(5):493-9. PubMed ID: 3412489
    [Abstract] [Full Text] [Related]

  • 28. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H, Hidaka K, Miyata K, Kamato T, Nishida A, Honda K.
    J Pharmacol Exp Ther; 1992 Dec 18; 263(3):1127-32. PubMed ID: 1469624
    [Abstract] [Full Text] [Related]

  • 29. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors.
    Hussy N, Lukas W, Jones KA.
    J Physiol; 1994 Dec 01; 481 ( Pt 2)(Pt 2):311-23. PubMed ID: 7537814
    [Abstract] [Full Text] [Related]

  • 30. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D, Neijt HC.
    Mol Pharmacol; 1988 Mar 01; 33(3):303-9. PubMed ID: 3352595
    [Abstract] [Full Text] [Related]

  • 31. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.
    Göthert M, Hamon M, Barann M, Bönisch H, Gozlan H, Laguzzi R, Metzenauer P, Nickel B, Szelenyi I.
    Br J Pharmacol; 1995 Jan 01; 114(2):269-74. PubMed ID: 7881726
    [Abstract] [Full Text] [Related]

  • 32. Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma x glioma cells.
    Boeijinga PH, Galvan M, Baron BM, Dudley MW, Siegel BW, Slone AL.
    Eur J Pharmacol; 1992 Aug 14; 219(1):9-13. PubMed ID: 1397053
    [Abstract] [Full Text] [Related]

  • 33. Actions of general anaesthetics on 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Jenkins A, Franks NP, Lieb WR.
    Br J Pharmacol; 1996 Apr 14; 117(7):1507-15. PubMed ID: 8730747
    [Abstract] [Full Text] [Related]

  • 34. The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Sepúlveda MI, Lummis SC, Martin IL.
    Br J Pharmacol; 1991 Oct 14; 104(2):536-40. PubMed ID: 1797317
    [Abstract] [Full Text] [Related]

  • 35. Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.
    Barann M, Göthert M, Brüss M, Bönisch H.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep 14; 360(3):234-41. PubMed ID: 10543423
    [Abstract] [Full Text] [Related]

  • 36. Alcohols potentiate the function of 5-HT3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state.
    Zhou Q, Verdoorn TA, Lovinger DM.
    J Physiol; 1998 Mar 01; 507 ( Pt 2)(Pt 2):335-52. PubMed ID: 9518697
    [Abstract] [Full Text] [Related]

  • 37. The potential therapeutic role of the enantiomers and metabolites of mianserin.
    Pinder RM, Van Delft AM.
    Br J Clin Pharmacol; 1983 Mar 01; 15 Suppl 2(Suppl 2):269S-276S. PubMed ID: 6824558
    [Abstract] [Full Text] [Related]

  • 38. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J, Barnes JM, Towers P, Barnes NM.
    Eur J Pharmacol; 1997 Aug 13; 332(3):307-12. PubMed ID: 9300265
    [Abstract] [Full Text] [Related]

  • 39. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
    Boess FG, Sepúlveda MI, Lummis SC, Martin IL.
    Neuropharmacology; 1992 Jun 13; 31(6):561-4. PubMed ID: 1407396
    [Abstract] [Full Text] [Related]

  • 40. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC, Gunthorpe MJ, Taylor CW, Lummis SC.
    Mol Pharmacol; 1996 Nov 13; 50(5):1284-94. PubMed ID: 8913360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.